UnitedHealth Group’s (UNH) “Overweight” Rating Reiterated at Cantor Fitzgerald

Cantor Fitzgerald reiterated their overweight rating on shares of UnitedHealth Group (NYSE:UNH) in a research report report published on Tuesday, Benzinga reports. Cantor Fitzgerald currently has a $591.00 target price on the healthcare conglomerate’s stock.

Several other research analysts have also commented on UNH. Argus lifted their price target on UnitedHealth Group from $570.00 to $600.00 and gave the stock a buy rating in a research report on Wednesday, July 17th. Royal Bank of Canada increased their price target on shares of UnitedHealth Group from $555.00 to $615.00 and gave the stock an outperform rating in a research note on Wednesday, July 17th. TD Cowen lifted their price objective on shares of UnitedHealth Group from $546.00 to $601.00 and gave the company a buy rating in a research note on Wednesday, July 17th. Barclays boosted their price target on UnitedHealth Group from $560.00 to $604.00 and gave the company an overweight rating in a research report on Wednesday, July 17th. Finally, Morgan Stanley lifted their target price on UnitedHealth Group from $595.00 to $615.00 and gave the company an overweight rating in a research note on Wednesday, July 17th. Two analysts have rated the stock with a hold rating, eighteen have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of Moderate Buy and an average target price of $614.17.

UnitedHealth Group Trading Up 0.1 %

UNH opened at $592.75 on Tuesday. The business’s 50-day simple moving average is $581.82 and its 200-day simple moving average is $526.64. The company has a market cap of $547.36 billion, a P/E ratio of 36.23, a PEG ratio of 1.62 and a beta of 0.58. UnitedHealth Group has a one year low of $436.38 and a one year high of $607.94. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.88 and a current ratio of 0.88.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, July 16th. The healthcare conglomerate reported $6.80 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.66 by $0.14. UnitedHealth Group had a net margin of 3.66% and a return on equity of 26.55%. The business had revenue of $98.86 billion during the quarter, compared to analysts’ expectations of $98.73 billion. During the same quarter in the prior year, the business posted $6.14 EPS. The company’s revenue for the quarter was up 6.4% on a year-over-year basis. As a group, equities research analysts expect that UnitedHealth Group will post 27.69 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, September 24th. Stockholders of record on Monday, September 16th were given a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.42%. The ex-dividend date of this dividend was Monday, September 16th. UnitedHealth Group’s dividend payout ratio is currently 51.34%.

Insider Activity at UnitedHealth Group

In other news, EVP Erin Mcsweeney sold 1,500 shares of the stock in a transaction that occurred on Thursday, July 18th. The shares were sold at an average price of $579.03, for a total value of $868,545.00. Following the sale, the executive vice president now directly owns 7,785 shares in the company, valued at $4,507,748.55. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,500 shares of the stock in a transaction on Thursday, July 18th. The stock was sold at an average price of $579.03, for a total transaction of $868,545.00. Following the sale, the executive vice president now owns 7,785 shares in the company, valued at approximately $4,507,748.55. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, CAO Thomas E. Roos sold 2,851 shares of the company’s stock in a transaction on Wednesday, July 17th. The shares were sold at an average price of $569.88, for a total value of $1,624,727.88. Following the completion of the sale, the chief accounting officer now owns 29,501 shares in the company, valued at $16,812,029.88. The disclosure for this sale can be found here. 0.33% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

Several institutional investors have recently bought and sold shares of the business. Macroview Investment Management LLC boosted its stake in UnitedHealth Group by 671.4% in the 2nd quarter. Macroview Investment Management LLC now owns 54 shares of the healthcare conglomerate’s stock worth $28,000 after buying an additional 47 shares during the last quarter. Delos Wealth Advisors LLC raised its stake in UnitedHealth Group by 757.1% during the first quarter. Delos Wealth Advisors LLC now owns 60 shares of the healthcare conglomerate’s stock worth $30,000 after purchasing an additional 53 shares during the period. True Wealth Design LLC acquired a new stake in shares of UnitedHealth Group during the 4th quarter worth $31,000. Bbjs Financial Advisors LLC purchased a new stake in UnitedHealth Group during the second quarter valued at about $31,000. Finally, Global Wealth Strategies & Associates lifted its stake in shares of UnitedHealth Group by 152.4% in the 3rd quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock valued at $31,000 after purchasing an additional 32 shares in the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.